Our COVID Vaccine Statement and other related resources for patients and our researchers and research staff are available on the COVID-19 Updates webpage.
Kathleen Moore MD
Closed to Accrual
To determine if the addition of adjuvant chemotherapy to standard cisplatin-based chemo-radiation improves overall survival.
Patients with stage IB1 & positive nodes, IB2, II, IIIB or IVA cervical cancer suitable for primary treatment with chemo-radiation with curative intent.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.